Evidence map›Paper›PMID 22706967›Full record

ArticleEuropean journal of immunology2012

Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus.

Henry J McSorley, Mary T O'Gorman, Natalie Blair, Tara E Sutherland, Kara J Filbey, Rick M Maizels

Abstract read
In one paragraph

Article in European journal of immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A secreted fatty acid- and retinol- binding protein frombioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Critical and diverse role of alarmin cytokines in parasitic infections.Frontiers in cellular and infection microbiology · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Profiles of CD4Medical microbiology and immunology · 2022
    Article
  15. Review
  16. Mining Anti-Inflammation Molecules FromFrontiers in cellular and infection microbiology · 2021
    Article
  17. Review
  18. Article
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Henry J McSorleyInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK.
Mary T O'Gorman
Natalie Blair
Tara E Sutherland
Kara J Filbey
Rick M Maizels
University of Edinburgh · GBZero to Three · US

Funding

Medical Research Council G0501474Wellcome Trust 090281
6 · The paper itself

Abstract

Allergic asthma is less prevalent in countries with parasitic helminth infections, and mice infected with parasites such as Heligmosomoides polygyrus are protected from allergic airway inflammation. To establish whether suppression of allergy could be mediated by soluble products of this helminth, we tested H. polygyrus excretory-secretory (HES) material for its ability to impair allergic inflammation. When HES was added to sensitising doses of ovalbumin, the subsequent allergic airway response was suppressed, with ablated cell infiltration, a lower ratio of effector (CD4(+) CD25(+) Foxp3(-) ) to regulatory (CD4(+) Foxp3(+) ) T (Treg) cells, and reduced Th1, Th2 and Th17 cytokine production. HES exposure reduced IL-5 responses and eosinophilia, abolished IgE production and inhibited the type 2 innate molecules arginase-1 and RELM-α (resistin-like molecule-α). Although HES contains a TGF-β-like activity, similar effects in modulating allergy were not observed when administering mammalian TGF-β alone. HES also protected previously sensitised mice, suppressing recruitment of eosinophils to the airways when given at challenge, but no change in Th or Treg cell populations was apparent. Because heat-treatment of HES did not impair suppression at sensitisation, but compromised its ability to suppress at challenge, we propose that HES contains distinct heat-stable and heat-labile immunomodulatory molecules, which modulate pro-allergic adaptive and innate cell populations.

Indexed as

Therapy with HelminthsAnimalsAntigens, HelminthArginaseAsthmaCell MovementCells, CulturedCytokinesEosinophilsHumansImmunoglobulin EImmunosuppression TherapyIntercellular Signaling Peptides and ProteinsMiceMice, Inbred BALB CNematospiroides dubiusAntigens, HelminthArg1 protein, mouseArginaseCytokinesImmunoglobulin EIntercellular Signaling Peptides and ProteinsRetnla protein, mouse

Identifiers

PMID22706967
PMCPMC4916998
OpenAlexW2099473703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.